Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Donor-transmitted, donor-derived, and de novo cancer after liver transplant.

Chapman JR, Lynch SV.

Exp Clin Transplant. 2014 Mar;12 Suppl 1:50-4. Review.

2.

Donor transmitted and de novo cancer after liver transplantation.

Desai R, Neuberger J.

World J Gastroenterol. 2014 May 28;20(20):6170-9. doi: 10.3748/wjg.v20.i20.6170. Review.

3.

Neoplastic disease after liver transplantation: Focus on de novo neoplasms.

Burra P, Rodriguez-Castro KI.

World J Gastroenterol. 2015 Aug 7;21(29):8753-68. doi: 10.3748/wjg.v21.i29.8753. Review.

4.

Burden of de novo malignancy in the liver transplant recipient.

Chandok N, Watt KD.

Liver Transpl. 2012 Nov;18(11):1277-89. doi: 10.1002/lt.23531. Epub 2012 Sep 26. Review.

5.

Posttransplant malignancies in liver transplant recipients.

Akdur A, Kırnap M, Yıldırım S, Altundağ Ö, Moray G, Haberal M.

Exp Clin Transplant. 2014 Mar;12 Suppl 1:162-5.

6.

Donor-derived metastatic melanoma in a liver transplant recipient established by DNA fingerprinting.

Bilal M, Eason JD, Das K, Sylvestre PB, Dean AG, Vanatta JM.

Exp Clin Transplant. 2013 Oct;11(5):458-63. doi: 10.6002/ect.2012.0243. Epub 2013 Mar 26.

7.

Tumours after kidney transplantation.

Lutz J, Heemann U.

Curr Opin Urol. 2003 Mar;13(2):105-9. Review.

PMID:
12584469
8.

Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.

Kelly DM, Emre S, Guy SR, Miller CM, Schwartz ME, Sheiner PA.

Cancer. 1998 Sep 15;83(6):1237-43.

PMID:
9740091
9.

Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review.

Chak E, Saab S.

Liver Int. 2010 Oct;30(9):1247-58. doi: 10.1111/j.1478-3231.2010.02303.x. Review.

PMID:
20602682
10.

What has changed in more than 40 years of activity and 3000 kidney transplants at Policlinico University Hospital, Milan.

Berardinelli L, Raiteri M, Beretta C, Pasciucco A, Giussani A, Carini M, Marenghi C, Rossetti A, Piccolo G.

Clin Transpl. 2011:99-110.

PMID:
22755406
11.

De novo malignancies after liver transplantation: a major cause of late death.

Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B.

Liver Transpl. 2001 Nov;7(11 Suppl 1):S109-18. Review.

12.

Impact of center volume on outcomes of increased-risk liver transplants.

Ozhathil DK, Li YF, Smith JK, Tseng JF, Saidi RF, Bozorgzadeh A, Shah SA.

Liver Transpl. 2011 Oct;17(10):1191-9. doi: 10.1002/lt.22343.

13.

De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.

Baccarani U, Adani GL, Montanaro D, Risaliti A, Lorenzin D, Avellini C, Tulissi P, Groppuzzo M, Currò G, Luvisetto F, Beltrami A, Bresadola V, Viale PL, Bresadola F.

Transplant Proc. 2006 May;38(4):1135-7.

PMID:
16757287
14.

De novo cancer-related death in Australian liver and cardiothoracic transplant recipients.

Na R, Grulich AE, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM.

Am J Transplant. 2013 May;13(5):1296-304. doi: 10.1111/ajt.12192. Epub 2013 Mar 6.

15.

Development of organ-specific donor risk indices.

Akkina SK, Asrani SK, Peng Y, Stock P, Kim WR, Israni AK.

Liver Transpl. 2012 Apr;18(4):395-404. doi: 10.1002/lt.23398. Review.

16.

Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances.

Said A.

World J Gastroenterol. 2013 Dec 28;19(48):9146-55. doi: 10.3748/wjg.v19.i48.9146. Review.

17.

Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.

Wimmer CD, Angele MK, Schwarz B, Pratschke S, Rentsch M, Khandoga A, Guba M, Jauch KW, Bruns C, Graeb C.

Transpl Int. 2013 Oct;26(10):999-1006. doi: 10.1111/tri.12165. Epub 2013 Aug 17.

18.

Results of liver transplants from donors aged 70 plus: analysis of Andalusian transplant register.

Franco CC, Martínez JM, Bellido CB, Artacho GS, Gómez LM, Diez-Canedo JS, Aunión CD, Ruiz FJ, Bravo MA.

Transplant Proc. 2013;45(10):3647-9. doi: 10.1016/j.transproceed.2013.10.024.

PMID:
24314984
19.

[Risk of cancer in patients following chronic dialysis and kidney graft].

Janus N, Launay-Vacher V, Ferrero JM, Thariat J.

Bull Cancer. 2012 Mar 1;99(3):285-93. doi: 10.1684/bdc.2012.1545. Review. French.

20.

Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.

Zhou J, Hu Z, Zhang Q, Li Z, Xiang J, Yan S, Wu J, Zhang M, Zheng S.

PLoS One. 2016 May 12;11(5):e0155179. doi: 10.1371/journal.pone.0155179. eCollection 2016.

Supplemental Content

Support Center